TransCode Therapeutics shares are trading lower by 16% during Monday's session. The company announced a 1-for-33 reverse stock split. Unlock your all-in-one trading dashboard with real-time alerts, ...
(RTTNews) - TransCode Therapeutics, Inc. (RNAZ), a biopharmaceutical company, on Monday, announced a 1-for-20 reverse stock split effective May 23. The common stock of TransCode will begin trading on ...
BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to more effectively treating cancer using RNA ...
Transcode Therapeutics, a preclinical biotech developing RNA-based therapies for cancer, filed on Friday with the SEC to raise up to $30 million in an initial public offering. Transcode is an emerging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results